AHAlexander L. Hopkirk

Alexander L. Hopkirk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexander L. Hopkirk has a total of 93 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mapping histologic and functional maturation of human endocrine pancreas across early postnatal periods

    by Diane C. Saunders, Fan Feng, Alexander L. Hopkirk, Kristie I. Aamodt, Nathaniel Hart, Fong Cheng Pan, Conrad V. Reihsmann, Nike Izmaylov, Shaojun Mei, Brandon A. Sherrod, et al.

    Human endocrine cell differentiation and islet morphogenesis play critical roles in determining islet cell mass and function, but the events and timeline of these processes are incompletely defined. To better understand early human islet cell development and maturation, we collected 123 pediatric pancreata and mapped morphological and spatiotemporal changes from birth through the first ten years of life. Using quantitative analyses and a combination of complementary tissue imaging approaches, including confocal microscopy and whole-slide multiplex imaging, we developed an integrated model for endocrine cell formation and islet architecture, including endocrine cell type heterogeneity and abundance, endocrine cell proliferation, and islet vascularization and innervation. We also assessed insulin and glucagon secretory profiles in isolated islet preparations from pediatric donors aged 2 months to 10 years and found a temporal difference in the maturation of insulin secretion compared to glucagon secretion. This comprehensive summary of postnatal and pediatric pancreatic islet development provides a framework for future studies and for integrating emerging genetic and genomic data related to islet biology and diabetes risk.


  • Open Access

    Heterogeneous endocrine cell composition defines human islet functional phenotypes

    by Carmella Evans-Molina, Yasminye D. Pettway, Diane C. Saunders, Seth A. Sharp, Thomas Sr. Bate, Han Sun, Heather Durai, Shaojun Mei, Anastasia Coldren, Corey Davis, et al.

    Phenotyping and genotyping initiatives within the Integrated Islet Distribution Program (IIDP), the largest source of human islets for research in the U.S., provide standardized assessment of islet preparations distributed to researchers and enable the integration of multiple data types. Data from islets of the first 299 organ donors without diabetes analyzed using this pipeline highlights substantial heterogeneity in islet cell composition associated with hormone secretory traits, sex, reported race and ethnicity, genetically predicted ancestry, and genetic risk for type 2 diabetes (T2D). While α and β cell composition influenced insulin and glucagon secretory traits, the abundance of δ cells showed the strongest association with insulin secretion and was also associated with the genetic risk score (GRS) for T2D. These findings have important implications for understanding mechanisms underlying diabetes heterogeneity and islet dysfunction and may provide insight into strategies for personalized medicine and β cell replacement therapy.


  • Open Access

    CelLink: integrating single-cell multi-omics data with weak feature linkage and imbalanced cell populations.

    by Xin Luo, Yuanhao Huang, Haoxuan Zeng, Yicheng Tao, Xinyu Bao, Fan Feng, Alexander L Hopkirk, Thai Pham, Thomas S R Bate, Diane C Saunders, et al.

    Single-cell multi-omics technologies capture complementary molecular layers, enabling a comprehensive view of cellular states and functions. However, integrating these data types poses significant challenges when their features are weakly linked and cell population sizes are imbalanced. Currently, no method efficiently addresses these two issues simultaneously. Therefore, we developed CelLink, a novel single-cell multi-omics data integration method designed to overcome these challenges. CelLink normalizes and smooths feature profiles to align scales across datasets and integrates them through a multi-phase pipeline that iteratively employs the optimal transport algorithm. It dynamically refines cell-cell correspondences, identifying and excluding cells that cannot be reliably matched, thus avoiding performance degradation caused by erroneous imputations. This approach effectively adapts to weak feature linkage and imbalanced cell populations between datasets. Benchmarking CelLink on scRNA-seq and spatial proteomics datasets, as well as paired CITE-seq data, demonstrates its superior performance across various evaluation metrics, including data mixing, cell manifold structure preservation, and feature imputation accuracy. Compared to state-of-the-art methods, CelLink significantly outperforms others in imbalanced cell populations while consistently achieving better performance for balanced datasets. Moreover, CelLink uniquely enables cell subtype annotation, correction of mislabeled cells, and spatial transcriptomic analyses by imputing transcriptomic profiles for spatial proteomics data. Its great ability to impute large-scale paired single-cell multi-omics data positions it pivotal for building single-cell multi-modal foundation models and spatial cellular biology.


  • Genetic risk converges on regulatory networks mediating early type 2 diabetes

    by John T. Walker, Diane C. Saunders, Vivek Rai, Hung-Hsin Chen, Peter Orchard, Chunhua Dai, Yasminye D. Pettway, Alexander L. Hopkirk, Conrad V. Reihsmann, Yicheng Tao, et al.

    Type 2 diabetes mellitus (T2D), a major cause of worldwide morbidity and mortality, is characterized by dysfunction of insulin-producing pancreatic islet β cells1,2. T2D genome-wide association studies (GWAS) have identified hundreds of signals in non-coding and β cell regulatory genomic regions, but deciphering their biological mechanisms remains challenging3,4,5. Here, to identify early disease-driving events, we performed traditional and multiplexed pancreatic tissue imaging, sorted-islet cell transcriptomics and islet functional analysis of early-stage T2D and control donors. By integrating diverse modalities, we show that early-stage T2D is characterized by β cell-intrinsic defects that can be proportioned into gene regulatory modules with enrichment in signals of genetic risk. After identifying the β cell hub gene and transcription factor RFX6 within one such module, we demonstrated multiple layers of genetic risk that converge on an RFX6-mediated network to reduce insulin secretion by β cells. RFX6 perturbation in primary human islet cells alters β cell chromatin architecture at regions enriched for T2D GWAS signals, and population-scale genetic analyses causally link genetically predicted reduced RFX6 expression with increased T2D risk. Understanding the molecular mechanisms of complex, systemic diseases necessitates integration of signals from multiple molecules, cells, organs and individuals, and thus we anticipate that this approach will be a useful template to identify and validate key regulatory networks and master hub genes for other diseases or traits using GWAS data.


  • Open Access

    RFX6-mediated dysregulation defines human β cell dysfunction in early type 2 diabetes

    by John T. Walker, Diane C. Saunders, Vivek Rai, Chunhua Dai, Peter Orchard, Alexander L. Hopkirk, Conrad V. Reihsmann, Yicheng Tao, Simin Fan, Shristi Shrestha, et al.

    SUMMARY: A hallmark of type 2 diabetes (T2D), a major cause of world-wide morbidity and mortality, is dysfunction of insulin-producing pancreatic islet β cells 1–3 . T2D genome-wide association studies (GWAS) have identified hundreds of signals, mostly in the non-coding genome and overlapping β cell regulatory elements, but translating these into biological mechanisms has been challenging 4–6 . To identify early disease-driving events, we performed single cell spatial proteomics, sorted cell transcriptomics, and assessed islet physiology on pancreatic tissue from short-duration T2D and control donors. Here, through integrative analyses of these diverse modalities, we show that multiple gene regulatory modules are associated with early-stage T2D β cell-intrinsic defects. One notable example is the transcription factor RFX6, which we show is a highly connected β cell hub gene that is reduced in T2D and governs a gene regulatory network associated with insulin secretion defects and T2D GWAS variants. We validated the critical role of RFX6 in β cells through direct perturbation in primary human islets followed by physiological and single nucleus multiome profiling, which showed reduced dynamic insulin secretion and large-scale changes in the β cell transcriptome and chromatin accessibility landscape. Understanding the molecular mechanisms of complex, systemic diseases necessitates integration of signals from multiple molecules, cells, organs, and individuals and thus we anticipate this approach will be a useful template to identify and validate key regulatory networks and master hub genes for other diseases or traits with GWAS data.